
|Articles|January 15, 2017
Increased Scrutiny of PBMs Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5

















































































































































































































